Distinguishing Anxiety from Akathisia
Akathisia is a medication-induced movement disorder characterized by subjective inner restlessness with objective motor agitation, while anxiety is a primary psychiatric condition characterized by excessive worry and fear—the critical distinction is that akathisia is drug-induced and includes an irresistible urge to move, whereas anxiety is primarily cognitive and emotional. 1, 2
Core Clinical Differences
Akathisia Features
Akathisia presents with both subjective and objective components that distinguish it from pure anxiety 1, 2:
- Subjective: Severe inner restlessness, motor tension, inability to tolerate inactivity, emotional unease
- Objective motor signs: Constant pacing, rocking while standing, fidgety movements while seated, purposeless leg/foot movements, inability to sit or stand still 3, 4
- Medication trigger: Always associated with dopamine-blocking agents (antipsychotics, antiemetics like metoclopramide/prochlorperazine) or serotonergic agents (SSRIs/SNRIs) 1, 2, 5
- Timing: Typically occurs within days to weeks of starting or increasing the offending medication 1
Anxiety Features
Anxiety disorders are characterized by 6, 7:
- Cognitive symptoms: Excessive, uncontrollable worry about multiple situations, apprehensive expectation, difficulty concentrating
- Emotional symptoms: Fear, nervousness, feeling keyed up or on edge
- Physical symptoms: Restlessness (but without the compelling urge to move), muscle tension, fatigue, sleep disturbance
- Duration: Symptoms present for at least 6 months for generalized anxiety disorder 7
- No medication trigger: Primary psychiatric condition, though can be worsened by substances
Critical Diagnostic Pitfall
The most dangerous clinical error is misdiagnosing akathisia as anxiety or psychotic agitation, which leads to increasing the antipsychotic dose—this worsens akathisia severity and can precipitate suicidal ideation 1, 2, 3. Akathisia is associated with increased suicidal thoughts and is severely distressing to patients 2, 4.
Practical Clinical Assessment
Key Questions to Ask
- "When did this restlessness start in relation to starting or changing medications?" - Akathisia has temporal relationship to medication changes
- "Do you feel like you MUST move, or do you just feel nervous?" - Akathisia involves an irresistible compulsion to move 3
- "Does the restlessness get worse when you try to sit still?" - Pathognomonic for akathisia 2
- "Have you had this medication-induced restlessness before?" - Patients who've experienced it can identify it 8
Observable Signs
- Watch the patient: Akathisia patients cannot remain still—they pace continuously, rock, shift weight, march in place 3, 4
- Anxiety patients: May appear tense but can sit relatively still during interview
- Timing observation: Akathisia symptoms worsen after dose increases or PRN antipsychotic use 3
Medication-Specific Considerations
High-Risk Medications for Akathisia
- Antipsychotics: High-potency agents (haloperidol) > low-potency agents 1
- Antiemetics: Metoclopramide, prochlorperazine 5, 9
- Antidepressants: SSRIs/SNRIs (25% incidence), particularly fluoxetine, fluvoxamine 8, 10, 11
- Other: Azithromycin 2
The evidence shows akathisia occurs in 14-35% of patients on antipsychotics 12 and 25% of patients on SSRIs/SNRIs 11—far more common than typically recognized.
Management Approach
If Akathisia is Diagnosed
First-line treatment 1, 13, 14:
- Reduce or discontinue the offending medication if clinically feasible
- Switch to lower-risk antipsychotic (quetiapine or olanzapine for akathisia) 13
- Pharmacological treatment based on 2024 network meta-analysis 12:
If Anxiety is Diagnosed
Treat according to anxiety disorder guidelines with CBT, SSRIs, or SNRIs 6—but monitor for paradoxical anxiety or akathisia development 10, 11.
Risk Factors for Akathisia
The distinction matters profoundly for patient safety: treating akathisia as anxiety by increasing antipsychotics can be catastrophic, while treating anxiety as akathisia by stopping necessary psychiatric medications can lead to relapse 1, 2.